ASEP Medical Holdings (XCNQ:ASEP) Inventories, Raw Materials & Components: C$0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XCNQ:ASEP ASEP Medical Holdings Inc XCNQ:ASEP
19 GF Score
Price C$0.13
! 4 Warning Signs
View Full Analysis

What is ASEP Medical Holdings Inventories, Raw Materials & Components?

ASEP Medical Holdings XCNQ:ASEP 19 Inventories, Raw Materials & Components is C$0.00 Mil as of Mar. 2026. GuruFocus rates XCNQ:ASEP with a GF Score™ of 19/100. The stock has 4 warning signs investors should review.

ASEP Medical Holdings's inventories, raw materials & components for the quarter that ended in Mar. 2026 was C$0.00 Mil.

ASEP Medical Holdings Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for ASEP Medical Holdings's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ASEP Medical Holdings Inventories, Raw Materials & Components Chart

ASEP Medical Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
0.00 0.00 0.00 0.00 0.00

ASEP Medical Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XCNQ:ASEP
19GF Score
ASEP Medical Holdings Inc XCNQ:ASEP
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ASEP Medical Holdings Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of C$0.00 Mil mean?
ASEP Medical Holdings (XCNQ:ASEP) has a Inventories, Raw Materials & Components of C$0.00 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on ASEP Medical Holdings and its competitors.
Is ASEP Medical Holdings' Inventories, Raw Materials & Components too high?
ASEP Medical Holdings' current Inventories, Raw Materials & Components is C$0.00 Mil. Overall, ASEP Medical Holdings has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does ASEP Medical Holdings' Inventories, Raw Materials & Components compare to VRTX and REGN?
ASEP Medical Holdings' Inventories, Raw Materials & Components of C$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Biotechnology company?
A good Inventories, Raw Materials & Components depends on the Biotechnology industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on ASEP Medical Holdings and its competitors. ASEP Medical Holdings's current Inventories, Raw Materials & Components is C$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ASEP Medical Holdings stock overvalued right now?
ASEP Medical Holdings (XCNQ:ASEP) has a current Inventories, Raw Materials & Components of C$0.00 Mil. The current Inventories, Raw Materials & Components is C$0.00 Mil. ASEP Medical Holdings' overall GF Score™ is 19/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For ASEP Medical Holdings (XCNQ:ASEP), the current Inventories, Raw Materials & Components is C$0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ASEP Medical Holdings Business Description

Other Exchanges JJ80:Germany
Address 4400 Chatterton Way, Unit 202, Victoria, BC, CAN, V8X 5J2
ASEP Medical Holdings Inc is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. Diagnostic and therapeutic solutions represent tremendous clinical and commercial potential, through rapid diagnostics and uniquely effective treatments. Its Diagnostic has developed a novel diagnostic assay for the early and rapid risk assessment of sepsis. Therapeutic offering: Patented peptide technology targets infection-causing biofilms and reduces inflammation.
19GF Score

Get the complete analysis for XCNQ:ASEP

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.13
Price